SEC Form 4 · accession 0001209191-15-057219
Seres Therapeutics, Inc. · MCRB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Werner Cautreels
Director
Period of report
Jun 25, 2015
Accepted (ET)
Jun 29, 2015 · 6:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609809
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $18.00 | Jun 25, 2015 | A | 15,000 | A | — | Jun 24, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option will vest as to 25% of the shares on June 25, 2016. The remainder of the shares will vest in 12 equal quarterly installments thereafter.